在未培养细胞微阵列检测基础上,培养羊水细胞集落核型分析对确认异常无创产前检测结果的附加价值有限
该回顾性研究评估在未培养羊水细胞SNP微阵列外,加做培养羊水细胞集落核型分析对发现胎儿嵌合体的附加价值。2014年4月至2021年12月共368例因无创产前检测提示染色体异常而行羊膜腔穿刺,204例符合条件。196例(96%)培养与未培养细胞结果一致,5例(2%)培养细胞嵌合而未培养细胞正常,其中2例(1%)考虑为真性胎儿嵌合体。
要点
- 204例中196例(96%)培养与未培养羊水细胞结果一致。
- 5例(2%)培养细胞显示嵌合而未培养细胞正常。
- 仅2例(1%)为真性胎儿嵌合体,附加价值有限。
核心结论
- 在未培养羊水细胞SNP微阵列外增加培养羊水细胞集落分析,附加价值仅限于204例中的2例(1%),即否则会漏诊的真性胎儿嵌合体。
- 其中1例(13三体)的临床相关性未知,另1例同时存在超声异常并决定了妊娠管理。
- 这似乎支持将产前细胞遗传学确认检测限于未培养羊水细胞的SNP微阵列,从而大幅缩短报告时间。
研究设计与样本
- 回顾性研究,评估在未培养羊水细胞分析外增加培养羊水细胞集落分析对检测胎儿嵌合体的附加价值。
- 无创产前检测作为荷兰TRIDENT研究的一部分进行。
- 未培养羊水细胞采用单核苷酸多态性(SNP)微阵列进行细胞遗传学检测。
- 培养羊水细胞集落(原位法)采用荧光原位杂交和/或核型分析检测。
- 2014年4月至2021年12月共368例因无创产前检测发现染色体异常而行羊膜腔穿刺,排除134例常见非整倍体(经定量荧光聚合酶链反应确认)、29例仅检测未培养细胞和1例未知情同意后,204例纳入分析。
主要发现
- 204例中196例(96%)未培养与培养细胞结果一致,表现为正常、异常或嵌合。
- 5例(2%)培养羊水细胞显示嵌合而未培养羊水细胞正常。
- 5例中2例(1%)考虑为真性胎儿嵌合体,分别为嵌合型13三体和嵌合型16三体。
- 1例(13三体)的临床相关性未知,另1例同时存在超声异常并决定了妊娠管理。
关键数值与推荐
- 常见非整倍体经定量荧光聚合酶链反应确认后排除。
- 未培养羊水细胞采用SNP微阵列检测,培养羊水细胞集落采用荧光原位杂交和/或核型分析检测。
临床怎么用
- 作者认为,这似乎支持将产前细胞遗传学确认检测限于未培养羊水细胞的SNP微阵列,从而大幅缩短报告时间。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Non-invasive prenatal testing (NIPT) allows the detection of placental chromosome aberrations. To verify whether the fetus also has the chromosome aberration, diagnostic follow-up testing is required. The aim of this retrospective study was to assess the added value of analyzing amniotic fluid (AF) cell cultures in addition to uncultured AF cells for the detection of fetal mosaicism. METHOD: NIPT was performed as part of the Dutch TRIDENT study. Cytogenetic studies in uncultured AF were performed using single nucleotide polymorphism (SNP)-array. Cultured AF cell colonies (in situ method) were investigated with fluorescent in situ hybridization and/or karyotyping. Clinical outcome data were collected in cases with discordant results. RESULTS: Between April 2014 and December 2021, 368 amniocenteses were performed after a chromosomal aberration was detected with NIPT. Excluding 134 cases of common aneuploidies (confirmed by quantitative fluorescence polymerase chain reaction), 29 cases with investigation of uncultured cells only and 1 case without informed consent, 204 cases were eligible for this study. In 196 (96%) cases, the results in uncultured and cultured cells were concordant normal, abnormal or mosaic. Five cases (2%) showed mosaicism in cultured AF cells, whereas uncultured AF cells were normal. Two (1%) of these, one mosaic trisomy 13 and one mosaic trisomy 16, were considered true fetal mosaics. CONCLUSION: The added value of investigating AF cell cultures in addition to uncultured cells is limited to two of 204 (1%) cases in which true fetal mosaicsm would otherwise be missed. The clinical relevance of one (trisomy 13) remained unknown and the other case also showed ultrasound anomalies, which determined pregnancy management. This seems to justify limiting prenatal cytogenetic confirmatory testing to SNP arrays on uncultured AF cells, considerably shortening the reporting time.
引用
- Donze SH, Srebniak MI, Diderich KEM, et al. Limited additional value of karyotyping cultured amniotic fluid cell colonies in addition to microarray on uncultured cells for confirmation of abnormal non-invasive prenatal testing results. Prenat Diagn. 2023. PMID: 38141050. doi:10.1002/pd.6499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。